Alzheimer’s Center

Our approach to care

We offer disease-modifying therapies for eligible patients with early-stage Alzheimer’s disease. These therapies have been shown to slow memory decline in some patients.

• Eligibility: Based on cognitive testing, neurological exams, medical history, and brain MRI.
• Informed decision making: Your care team reviews how these medications work, the benefits and risks, and safety monitoring.
• Infusion and follow-up care: Medications are given at designated infusion centers. Lecanemab is administered every two weeks and donanemab every four weeks, with clinic visits typically every six months.
• MRI safety monitoring: Brain MRIs are required during the first six months of treatment, along with periodic check-ins from your care team.

Although there is no single definitive test for Alzheimer’s disease, our specialists use a comprehensive evaluation to diagnose the condition and rule out other causes of memory loss. Diagnostic testing may include:

• Neurological exam
• Cognitive and mental status testing
• Neuropsychological and neuropsychiatric assessment
• Brain imaging
• Blood tests
• Spinal fluid tests

Treatment plans are based on your symptoms, disease stage, overall health, and the goals of you and your family. Care may include:

• Medications to support cognitive function and manage symptoms
• Education, counseling, and future planning support
• Treatment of other medical conditions that may affect brain health
• Psychiatry and mental health services, when needed